Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 55150-296

This is a description of a medication with the NDC number 55150-209-02, named Dexmedetomi. It is a concentrate provided in a 2 mL single-dose vial to be diluted before use. It is distributed by AuroMedics Pharma LLC in E. Windsor, NJ, and is manufactured in India. It can only be administered intravenously and is available only with prescription.*

Not available.*

This is description for Dexmedetomidine Injection provided by AuroMedics Pharma LLC. Each ml contains 4 mcg of dexmedetomidine and 9 mg of sodium chloride in water for intravenous infusion. It is supplied in 50ml single-dose flexible containers and should not be diluted. It is ready to use and must not be used in series connections. The usual dosage should be consulted in the insert. The product must be stored at the temperature range of 20°C to 25°C (controlled room temperature) and unused portion should be discarded. The solution is preservative-free and caution should be taken to check for minute leaks by squeezing the container as sterility may be impaired.*

This is a package of Dexmedetomidine HCI in 0.9% Sodium Chloride Injection with a concentration of 4 mcg/mL contained in a 50mL Single Dose Flexible Container for intravenous infusion. The solution is ready to use and should not be diluted. To use, tear the foil pouch at the notch. Caution should be taken to ensure there are no leaks in the container, which may impair sterility. The usual dosage should be done as recommended in the insert. It should be stored at 20° to 25°C (68° to 77°F) and should not be frozen. The product should be discarded if the solution is not clear or the container is damaged. The package contains a moisture barrier overwrap to maintain sterility, which should not be removed until ready to use. This product was distributed by AuroMedics Pharma LLC and made in India.*

This is a description of a medication called Dexmedetomidine HCI that is sold in a set of 10, 50mL single-dose flexible containers. It is sterile and ready to use as an intravenous infusion, with a usual dosage to be found in the insert. Each 50mL container contains 200 micrograms of the medication. The pH level is between 4.50 and 7.0. The medication should not be administered along with blood or plasma through the same intravenous catheter. The medication should not be used in series connections. The product must not be used if the overwrap has been opened or damaged, and unused portions should be discarded. It is manufactured by AuroMedics Pharma LLC in India.*

This is a description of a medication, dexmedetomidine HCI, which comes in a single-dose flexible container with 400 mcg per 100 mL. It is meant for intravenous infusion and is ready to use without any dilution. The medication comes with 4.72 mcg of dexmedetomidine HCI USP, 9 mg of sodium chloride, and has a pH range from 4.5 to 7.0. It comes with a caution to check for minute leaks in the container and has instructions for storage and disposal of unused portions. It is also noted that the medication is preservative-free.*

This is a description of a medication product containing Dexmedetomidine HCI in a 100mL single-dose flexible container. It is provided in 0.9% Sodium Chloride injection and ready for intravenous infusion without any need for dilution. Each mL contains 4 mcg of dexmedetomidine with some sodium chloride and water for adjustment, and it has a pH between 4.5 to 7.0. It is for sterile Rx use only and must not be used in series connections. The usual dosage must be checked in the insert. Before use, the overwrap should be checked for damage or leaks. This product is preservative-free and should be stored between 20°C to 25°C. If it has been previously opened or damaged, the product must not be used. The product is distributed by AuroMedics Pharma LLC in India.*

This is a 100 mL single-dose flexible container of Dexmedetomidine HCI in 0.9% Sodium Chloride Injection for intravenous infusion. Each mL contains 4 meg of dexmedetomidine HCI USP and 9 mg of sodium chloride in water for injection. The solution is ready to use and should not be diluted. The usual dosage instructions are provided in the insert. The container must not be used in series connections and should not be co-administered through the same intravenous catheter with blood or plasma. It is distributed by AuroMedics Pharma LLC and should be stored at controlled room temperature. The packaged product is sterile and should not be used if there is any damage to the packaging. No other information is provided.*

The text is not-available.*